Calithera Achieves Positive Topline Results in Randomized Phase 2 ENTRATA Study of Telaglenastat with Everolimus in Renal Cell Carcinoma

NEXT STORY
Laboratory Reagents – World Market to 2022: Molecular Biology, Biochemistry, Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing
PREV STORY
Global Aromatherapy Market by Product, Mode of Delivery, Application, Distribution Channel, and End-use – Forecast to 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bellicum Pharmaceuticals Appoints Dr. William Grossman as Chief Medical Officer

HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing ...

author_avatar
NASDAQ Market News

Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting

author_avatar
NASDAQ Market News

Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

author_avatar
NASDAQ Market News